As of December 2024 Blueprint Medicines has a market cap of €5.82 Billion. This makes Blueprint Medicines the world's 2409th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 17th, 2024 the market cap of Blueprint Medicines was reported to be: